Clinical Trials Logo

Clinical Trial Summary

A total of 145 Liver transplantation (LT) recipients with hepatocellular carcinoma (HCC) were retrospectively enrolled at Kaohsiung Chang Gung Memorial Hospital between 2006 and 2019. Clinical records from 7 days before LT (pre-LT) to 1 year after LT (post-LT) were analysed. In a prospective study from March 2022 to June 2023, 20 lymphopenia and 25 non-lymphopenia HCC recipients were enrolled, and a phenotypic analysis of peripheral blood lymphocytes was performed using multiparameter flow cytometry.


Clinical Trial Description

A total of 145 Liver transplantation (LT) recipients with hepatocellular carcinoma (HCC) were retrospectively enrolled at Kaohsiung Chang Gung Memorial Hospital between 2006 and 2019. Clinical records from 7 days before LT (pre-LT) to 1 year after LT (post-LT) were analysed including overall survival, recurrence-free survival, association between clinical parameter with mortality, patient characteristics by pre-lymphopenia and post-lymphopenia levels and lymphocyte status of HCC patients with usage of different immunosuppressants. In prospective study from March 2022 to June 2023, 20 lymphopenia and 25 non-lymphopenia HCC recipients were enrolled, and a phenotypic analysis of peripheral blood lymphocytes was performed using multiparameter flow cytometry to identify the major immune cell subsets and the characteristics of patients in the prospective cohort between pre-LT lymphopenia and non-lymphopenia groups. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06368349
Study type Observational
Source Chang Gung Memorial Hospital
Contact
Status Completed
Phase
Start date March 1, 2022
Completion date June 30, 2023

See also
  Status Clinical Trial Phase
Terminated NCT02659800 - Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas Phase 1
Completed NCT00771810 - Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer Phase 2
Completed NCT00477321 - Safety Study of IL-7 in HIV-infected Patients (Inspire) Phase 1
Completed NCT04910230 - Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19 N/A
Completed NCT04800731 - Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19
Completed NCT04404608 - Etiology of Lymphopenia in Covid19 Infection
Recruiting NCT06181656 - Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
Completed NCT02698683 - Lymphocyte Count as a Sign of Immunoparalysis and Its Correlation With Nutritional Status in Septic Pediatric Patients N/A
Completed NCT05889169 - Stroke-induced Immunodepression in Neurorehabilitation
Withdrawn NCT01660347 - Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant N/A